HiMedia receives CE-IVD approval for Hi-PCR COVID-FLU Multiplex Probe PCR Kit (MBPCR262)

HiGenoMB Molecular Biology Division of Mumbai-based HiMedia Laboratories adds another feather in the cap with their newly CE/IVD approved Hi-PCR COVID-FLU Multiplex Probe PCR Kit (MBPCR262). Molecular Diagnostics based on real-time PCR is increasingly becoming the gold standard post COVID-19. Hi-PCR COVID-FLU Multiplex Probe PCR Kit is a multiplex PCR kit that can differentiate between COVID-19 and Flu using a single tube reaction. It is recommended for sensitive and specific detection of SARS-CoV-2 and Influenza virus in clinical samples. Targets include RdRp gene of SARSCoV-2 virus, Influenza A virus (Swine flu 2009 H1N1 virus, seasonal H3N2 & seasonal H1N1), Influenza B virus and Internal control (IC). As the public’s concern of contracting COVID-19 continued to rise, flu symptoms were frequently mistaken for those of COVID-19. Performing separate tests for detection of COVID-19 and Influenza can be time consuming, costly and a cumbersome affair. HiMedia’s MBPCR262 being a multiplex kit eliminates the need for separate tests thereby significantly reducing the time and resources.